Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 6, Number 2, February 2008

Free Content Recollections on thrombin generation
pp. 219-226(8)
Author: HEMKER, H. C.

Favourites:
ADD

Free Content Double-blind studies are not always optimum for evaluation of a novel therapy: the case of new anticoagulants
pp. 227-229(3)
Authors: BÜLLER, H. R.; HALPERIN, J. L.; BOUNAMEAUX, H.; PRINS, M.

Favourites:
ADD

Free Content Double-blindness protects scientific validity
pp. 230-231(2)
Authors: FURBERG, C. D.; SOLIMAN, E. Z.

Favourites:
ADD

Free Content Open-label trials and drug registration: a European regulator’s view
pp. 232-234(3)
Authors: CASTEELS, M.; FLAMION, B.

Favourites:
ADD
Favourites:
ADD

Free Content Venous thromboembolism and subsequent short-term risk of an occult cancer
pp. 249-250(2)
Authors: SØRENSEN, H. T.; JOHNSEN, S. P.

Favourites:
ADD

Free Content Clinical outcome in patients with venous thromboembolism and hidden cancer: findings from the RIETE Registry
pp. 251-255(5)
Authors: TRUJILLO-SANTOS, J.; PRANDONI, P.; RIVRON-GUILLOT, K.; ROMÁN, P.; SÁNCHEZ, R.; TIBERIO, G.; MONREAL, M.

Favourites:
ADD

Free Content Relationship between markers of activated coagulation, their correlation with inflammation, and association with coronary heart disease (NPHSII)
pp. 259-267(9)
Authors: MILLER, G. J.; IRELAND, H. A.; COOPER, J. A.; BAUER, K. A.; MORRISSEY, J. H.; HUMPHRIES, S. E.; ESNOUF, M. P.

Favourites:
ADD

Free Content Thrombin activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in children
pp. 268-276(9)
Authors: EMONTS, M.; DE BRUIJNE, E. L. E.; GUIMARÃES, A. H. C.; DECLERCK, P. J.; LEEBEEK, F. W. G.; DE MAAT, M. P. M.; RIJKEN, D. C.; HAZELZET, J. A.; GILS, A.

Favourites:
ADD

Free Content Safety and pharmacokinetics of a recombinant factor VIII with pegylated liposomes in severe hemophilia A
pp. 277-283(7)
Authors: POWELL, J. S.; NUGENT, D. J.; HARRISON, J. A.; SONI, A.; LUK, A.; STASS, H.; GORINA, E.

Favourites:
ADD

Free Content Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants
pp. 284-290(7)
Authors: PENNING-VAN BEEST, F. J. A.; KOERSELMAN, J.; HERINGS, R. M. C.

Favourites:
ADD

Free Content Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk
pp. 291-296(6)
Authors: BACH, J.; ENDLER, G.; WINKELMANN, B. R.; BOEHM, B. O.; MAERZ, W.; MANNHALTER, C.; HELLSTERN, P.

Favourites:
ADD

Free Content Intraoperative pulmonary embolism and intracardiac thrombosis complicating liver transplantation: a systematic review
pp. 297-302(6)
Authors: WARNAAR, N.; MOLENAAR, I. Q.; COLQUHOUN, S. D.; SLOOFF, M. J. H.; SHERWANI, S.; de WOLF, A. M.; PORTE, R. J.

Favourites:
ADD

Free Content Tissue-specific hemostasis: role of tissue factor
pp. 303-305(3)
Author: MACKMAN, N.

Favourites:
ADD

Free Content Expression of human tissue factor under the control of the mouse tissue factor promoter mediates normal hemostasis in knock-in mice
pp. 306-314(9)
Authors: SNYDER, L. A.; RUDNICK, K. A.; TAWADROS, R.; VOLK, A.; TAM, S. H.; ANDERSON, G. M.; BUGELSKI, P. J.; YANG, J.

Favourites:
ADD

Free Content Enhancement of the enzymatic activity of activated coagulation factor IX by anti-factor IX antibodies
pp. 315-322(8)
Authors: SCHEIFLINGER, F.; DOCKAL, M.; ROSING, J.; KERSCHBAUMER, R. J.

Favourites:
ADD

Free Content A highly-sensitive plasma von Willebrand factor ristocetin cofactor (VWF:RCo) activity assay by flow cytometry
pp. 323-330(8)
Authors: CHEN, D.; DAIGH, C. A.; HENDRICKSEN, J. I.; PRUTHI, R. K.; NICHOLS, W. L.; HEIT, J. A.; OWEN, W. G.

Favourites:
ADD

Free Content Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura
pp. 331-338(8)
Authors: CAMILLERI, R. S.; COHEN, H.; MACKIE, I. J.; SCULLY, M.; STARKE, R. D.; CRAWLEY, J. T. B.; LANE, D. A.; MACHIN, S. J.

Favourites:
ADD

Free Content A viable mouse model of factor X deficiency provides evidence for maternal transfer of factor X
pp. 339-345(7)
Authors: TAI, S. J.; HERZOG, R. W.; MARGARITIS, P.; ARRUDA, V. R.; CHU, K.; GOLDEN, J. A.; LABOSKY, P. A.; HIGH, K. A.

Favourites:
ADD

Free Content Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor
pp. 346-351(6)
Authors: VAN VLIET, H. A. A. M.; BERTINA, R. M.; DAHM, A. E. A.; ROSENDAAL, F. R.; ROSING, J.; MORTEN SANDSET, P.; HELMERHORST, F. M.

Favourites:
ADD

Free Content Variations in fibrinolytic parameters and inhibin-A in pregnancy: related hypertensive disorders
pp. 352-358(7)
Authors: SARTORI, M. T.; SERENA, A.; SAGGIORATO, G.; CAMPEI, S.; FAGGIAN, D.; PAGNAN, A.; PATERNOSTER, D. M.

Favourites:
ADD

Free Content The active metabolite of prasugrel inhibits adenosine diphosphate- and collagen-stimulated platelet procoagulant activities
pp. 359-365(7)
Authors: FRELINGER, A. L.; JAKUBOWSKI, J. A.; LI, Y.; BARNARD, M. R.; LINDEN, M. D.; TARNOW, I.; FOX, M. L.; SUGIDACHI, A.; WINTERS, K. J.; FURMAN, M. I.; MICHELSON, A. D.

Favourites:
ADD

Free Content Immunologic and structural analysis of eight novel domain-deletion β3 integrin peptides designed for detection of HPA-1 antibodies
pp. 366-375(10)
Authors: STAFFORD, P.; GHEVAERT, C.; CAMPBELL, K.; PROULX, C.; SMITH, G.; WILLIAMSON, L. M.; RANASINGHE, E.; WATKINS, N. A.; HUNTINGTON, J. A.; OUWEHAND, W. H.

Favourites:
ADD

Free Content Three novel β3 domain-deletion peptides for the sensitive and specific detection of HPA-4 and six low frequency β3-HPA antibodies
pp. 376-383(8)
Authors: STAFFORD, P.; GARNER, S. F.; HUISKES, E.; KAPLAN, C.; KEKOMAKI, R.; SANTOSO, S.; TSUNO, N. H.; WATKINS, N. A.; OUWEHAND, W. H.

Favourites:
ADD

Free Content Incidence of diagnosis of subsegmental pulmonary emboli using multidetector row and single-detector row computed tomography
pp. 384-386(3)
Authors: NIJKEUTER, M.; KWAKKEL-VAN ERP, J. M.; KRUIP, M. J. H. A.; SOHNE, M.; BÜLLER, H. R.; LEEBEEK, F. W. G.; HUISMAN, M. V.

Favourites:
ADD

Free Content Testing aspirin resistance using the platelet function analyzer-100: some methodological caveats and considerations
pp. 386-388(3)
Authors: MADSEN, E. H.; SCHMIDT, E. B.; GEHR, N.; JOHANNESEN, N. L.; KRISTENSEN, S. R.

Favourites:
ADD

Free Content Type 2M von Willebrand disease: a variant of type 2A?
pp. 388-390(3)
Authors: BATLLE, J.; PÉREZ-RODRÍGUEZ, A.; FRANQUEIRA, M. D.; LÓPEZ-FERNÁNDEZ, M. F.

Favourites:
ADD

Free Content The association between protein S levels and anticoagulant activity of tissue factor pathway inhibitor type 1
pp. 393-395(3)
Authors: DAHM, A. E. A.; SANDSET, P. M.; ROSENDAAL, F. R.

Favourites:
ADD

Free Content An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1
pp. 395-397(3)
Authors: JEIMY, S. B.; KRAKOW, E. F.; FULLER, N.; TASNEEM, S.; HAYWARD, C. P. M.

Favourites:
ADD

Free Content Size isn’t everything
pp. 397-399(3)
Authors: KLINE, J. A.; ZEITOUNI, R.; HERNANDEZ-NINO, J.; ROSE, G. A.

Favourites:
ADD

Free Content Invitation to a debate on the serological criteria that define the antiphospholipid syndrome
pp. 399-401(3)
Authors: GALLI, M.; REBER, G.; DE MOERLOOSE, P.; DE GROOT, P. G.

Favourites:
ADD

Free Content Join ISTH
pp. 402-402(1)

Favourites:
ADD

Free Content ANNOUNCEMENTS
pp. 402-403(2)

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more